Curtis J Perry

5PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 01, 2025
Precancer exercise capacity and metabolism during tumor development coordinate the skeletal muscle-tumor metabolic competition.

Brooks P Leitner, Andin E Fosam, Won D Lee

|Nov 13, 2025
Molecular Characterization of Polyomavirus-Positive and Negative Merkel Cell Carcinoma.

Poorva Vaidya, Sharon Wu, Dave Bryant

|Jul 17, 2025
Interactions Among Tumor Subtype, PPARγ Expression, and Adipose Proliferation Shape Outcomes in Breast Cancer.

Aditya Shah, Katie Liu, Ryan Liu

|Jun 18, 2021
A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non-Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1.

Sarah A Weiss, Dijana Djureinovic, Shlomit Jessel

|Feb 14, 2018
Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity.

Curtis J Perry, Andrés R Muñoz-Rojas, Katrina M Meeth

Pageof 1